Navigation Links
Regeneron Announces Appointment of Joseph J. LaRosa as Senior Vice President, General Counsel and Secretary
Date:9/6/2011

sed drugs."

About Regeneron Pharmaceuticals Regeneron is a fully integrated biopharmaceutical company that discovers, develops, manufacturers, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST® (rilonacept) Injection for Subcutaneous Use, which is approved for the treatment of a rare inflammatory condition, Regeneron has completed Phase 3 clinical trials of rilonacept for a new indication and of product candidates EYLEA™ (aflibercept injection; VEGF Trap Eye) in diseases of the eye and ZALTRAP® (aflibercept) (VEGF Trap) in colorectal cancer.  EYLEA is currently under review with U.S. and European regulatory authorities.  Additional therapeutic candidates developed from proprietary Regeneron technologies for creating fully human monoclonal antibodies are in earlier stage development programs in rheumatoid arthritis, pain, cholesterol reduction, allergic and immune conditions, and cancer.  Additional information about Regeneron and recent news releases are available on www.regeneron.com.Contact Information:Michael Aberman, M.D.

Peter DworkinInvestor Relations

Corporate Communications914.345.7799

914.345.7640michael.aberman@regeneron.com

peter.dworkin@regeneron.com
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Regeneron Announces Review of Biologics License Application for EYLEA™ (aflibercept injection) Extended by Three Months by FDA
2. Regeneron Announces Presentation at the 29th Annual J.P. Morgan Healthcare Conference
3. Regeneron Announces Presentation at the 2010 Deutsche Bank BioFest
4. Regenerons Rilonacept Granted European Marketing Authorization for Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS)
5. Regeneron Pharmaceuticals and BioMed Realty Trust Host Ribbon-Cutting Ceremony at the Landmark at Eastview
6. BioMed Realty Trust Expands Landmark Leases With Regeneron Pharmaceuticals
7. Genprex Announces New Branding
8. BioMed Realty Announces Repurchase at Option of Holders and Redemption of 4.50% Exchangeable Senior Notes Due 2026
9. BioInformatics LLC Announces the Life Science Industry Awards on November 15, 2011 in Washington, DC
10. Jeunesse Global Announces New Medical Advisory Board Member and Admittance Into the Direct Selling Association (DSA).
11. BD Biosciences Announces Winners of Research Grant Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)...   Mapi expands Pharmacovigilance and Risk ... global Risk Management strength with the expanded breadth ... . Pharmacovigilance and Risk ... team that includes physicians, pharmacists, and numerous other ... navigating complex safety requirements throughout the product lifecycle. ...
(Date:3/31/2015)...  University of Illinois, Swanlund ... plenary session address on Monday, May 18 at the ... kicking off a week of more than 160 technical ... RF and microwave technologies with health. Dr. ... Circuits for the Skin," will focus on the experimental ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Diasome Pharmaceuticals, ... licensor, SDG, Inc., that a United States patent has ... insulin therapy. , Entitled “Lipid Construct for ... composition of matter claims related to the use of ... for enabling injected insulin to more effectively reach the ...
(Date:3/30/2015)... Winston-Salem, NC (PRWEB) March 30, 2015 ... Associates are pleased to announce the formation of ... clinical research centers specializing in the conduct of ... populations. VaxCorps clinical sites have successfully conducted ... extensive experience in seasonal and pandemic influenza as ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2PMG Research announces formation of VaxCorps with two industry-leading vaccine site networks 2
... Savvier consumers and competition from generic drugs have made ... maturity, more elusive.  At the same time, new technologies ... to support pharmaceutical brand growth. While biopharma ... brands, recent field research from Best Practices, LLC suggests ...
... 30, 2011 Amnis Corporation, a manufacturer of advanced cell ... by EMD Millipore, the Life Science division of Merck KGaA ... closing is expected to take place in the fourth quarter ... Amnis generated sales of USD 14 million ...
... crucial to preventing countless human diseases. In a recent ... a new approach for studying molecules within their natural ... how bacteria infect people. The research, led by ... in the Proceedings of the National Academy of ...
Cached Biology Technology:Using Public Relations to Launch, Grow, and Extend Pharmaceutical and Biotech Brands 2Amnis Acquired by EMD Millipore - Expands Growth Potential 2Amnis Acquired by EMD Millipore - Expands Growth Potential 3Scientists develop new technologies for understanding bacterial infections 2Scientists develop new technologies for understanding bacterial infections 3
(Date:3/17/2015)... MedNet Solutions , a global ... management systems, is pleased to announce that company ... in Clinical Trials Southeast conference – March 24-25 ... forum for MedNet to showcase iMedNet , ... eClinical technology platform. We strongly encourage ...
(Date:3/12/2015)... , March 12, 2015 The mascots of ... Children,s Hospital, part of Wake Forest Baptist Medical Center. ... for the 2015 ACC Men,s Basketball Tournament. Young patients ... them and getting their autographs. Brenner Children,s ... It is the only children,s hospital in northwest ...
(Date:3/10/2015)... -- Continuing its 167-year history of offering the Best, the ... Eye Scanning Password Authenticator , a device that confirms ... or sensitive data. Employing the same biometric ... device has a small camera that scans and saves ... them into an encrypted ID that cannot be forged ...
Breaking Biology News(10 mins):Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2
... Tenn., April 21, 2008 Improved management of crops ... the problem of hypoxia, which claims thousands of fish, ... spring. An assessment by a team led by ... Division concludes that low oxygen levels in water, or ...
... Virginia Bioinformatics Institute (VBI) at Virginia Tech and their ... family of virulence proteins that play an important role ... pathogen Phytophthora sojae. VBI Professor Brett Tyler ... from Virginia Techs Department of Plant Pathology, Physiology and ...
... results of a University of Illinois study have demonstrated an ... bars. Eating two CocoaVia dark chocolate bars a day ... also lowering systolic blood pressure, said John Erdman, a U. ... The study, funded in part by Mars Inc., the company ...
Cached Biology News:Crop management strategies key to a healthy Gulf, planet 2Crop management strategies key to a healthy Gulf, planet 3Chocolate bar shown to lower cholesterol 2
... The Ph.D. Peptide Display Cloning System ... on the surface of bacteriophage M13 as ... between each displayed peptide and its encoding ... of targets can then be selected by ...
... Detection of the yolk protein Vtg in ... simple and sensitive biomarker for endocrine disrupting chemicals ... Vtg has become an accepted screening test for ... Vtg (rainbow trout) EIA kit is a double-antibody ...
... synthetic peptide whose sequence corresponds to residues 115-133 of rat SAP97. ... V115 - L - P - S - E - ... - P - N - E - V - L - ... added to facilitate conjugation and is not a part of the ...
... Rapid-Screen cDNA Library Panels were designed for ... sets of PCRs to identify the desired ... performed in a 96-well "Master Plate," where ... clones. Having identified the positive well(s) by ...
Biology Products: